Physician profile
Simone Musco
NPI 1013181833
$6,954.64
in general payments reported to CMS, 2019-2025
13 companies · $520 in 2025
The $520 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $414 · 2020: $369 · 2021: $656 · 2022: $2,969 · 2023: $917 · 2024: $1,111 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,547.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,504.14 | 2019-2025 | Ensite, Ensite Precision, Amplatzer Amulet |
| E.R. Squibb & Sons, L.L.C. | $990.61 | 2019-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $733.56 | 2019-2025 | General - Crm_crm, Watchman Access System, Watchman Flx |
| Cook Medical LLC | $435.44 | 2022-2024 | Evolution |
| Medtronic, INC. | $369.63 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Azure Xt Dr Mri Surescan, Onyx Frontier |
| Novartis Pharmaceuticals Corporation | $219.79 | 2019-2024 | |
| Pfizer INC. | $198.63 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $195.73 | 2019-2023 | Xarelto |
| Biosense Webster, INC. | $169.80 | 2019-2022 | |
| Medtronic Vascular, INC. | $70.67 | 2019 | |
| Abiomed | $40.01 | 2024-2025 | Impella |
| Sanofi-Aventis U.S. LLC | $14.00 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simone Musco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.